X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DR. DATSONS LABS UNICHEM LAB/
DR. DATSONS LABS
 
P/E (TTM) x -33.5 -10.9 - View Chart
P/BV x 0.7 0.2 447.3% View Chart
Dividend Yield % 2.3 0.0 -  

Financials

 UNICHEM LAB   DR. DATSONS LABS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
DR. DATSONS LABS
Mar-14
UNICHEM LAB/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs382126 304.1%   
Low Rs23431 757.6%   
Sales per share (Unadj.) Rs116.3133.0 87.4%  
Earnings per share (Unadj.) Rs-18.90.2 -12,480.1%  
Cash flow per share (Unadj.) Rs-11.76.6 -177.7%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.60-  
Book value per share (Unadj.) Rs381.0128.8 295.8%  
Shares outstanding (eoy) m70.3431.66 222.2%   
Bonus/Rights/Conversions BBFCCB-  
Price / Sales ratio x2.60.6 450.2%   
Avg P/E ratio x-16.3516.1 -3.2%  
P/CF ratio (eoy) x-26.211.8 -221.6%  
Price / Book Value ratio x0.80.6 133.1%  
Dividend payout %-26.40-   
Avg Mkt Cap Rs m21,6682,477 874.6%   
No. of employees `0002.3NA-   
Total wages/salary Rs m2,00656 3,582.9%   
Avg. sales/employee Rs Th3,587.8NM-  
Avg. wages/employee Rs Th880.0NM-  
Avg. net profit/employee Rs Th-583.7NM-  
INCOME DATA
Net Sales Rs m8,1804,211 194.3%  
Other income Rs m61079 775.2%   
Total revenues Rs m8,7904,289 204.9%   
Gross profit Rs m-1,320569 -232.2%  
Depreciation Rs m505204 247.1%   
Interest Rs m80430 18.6%   
Profit before tax Rs m-1,29513 -10,199.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2-2 122.2%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m336 547.9%   
Profit after tax Rs m-1,3315 -27,727.5%  
Gross profit margin %-16.113.5 -119.5%  
Effective tax rate %-2.648.0 -5.4%   
Net profit margin %-16.30.1 -14,272.0%  
BALANCE SHEET DATA
Current assets Rs m23,3186,852 340.3%   
Current liabilities Rs m4,6356,711 69.1%   
Net working cap to sales %228.43.3 6,820.1%  
Current ratio x5.01.0 492.7%  
Inventory Days Days122161 75.7%  
Debtors Days Days121318 38.1%  
Net fixed assets Rs m8,1633,673 222.2%   
Share capital Rs m141317 44.4%   
"Free" reserves Rs m26,6603,761 708.9%   
Net worth Rs m26,8014,078 657.3%   
Long term debt Rs m31,671 0.2%   
Total assets Rs m31,89012,633 252.4%  
Interest coverage x-15.21.0 -1,473.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.30.3 77.0%   
Return on assets %-3.93.4 -113.9%  
Return on equity %-5.00.1 -4,218.5%  
Return on capital %-4.57.7 -59.2%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m4,356964 451.9%   
Fx outflow Rs m0607 0.0%   
Net fx Rs m4,356357 1,220.6%   
CASH FLOW
From Operations Rs m-1,1231,345 -83.5%  
From Investments Rs m16,487-2,256 -730.9%  
From Financial Activity Rs m-8,811-1,200 734.4%  
Net Cashflow Rs m6,552-2,111 -310.4%  

Share Holding

Indian Promoters % 50.1 4.5 1,106.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.0 -  
FIIs % 3.0 1.4 222.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 94.1 33.7%  
Shareholders   20,176 20,807 97.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   BIOCON LTD  WOCKHARDT LTD.  AUROBINDO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 150 Points Up; Oil & Gas Stocks Lead(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares show losses. The Nikkei 225 is up 0.3% while the Hang Seng is down 0.1%.

Related Views on News

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 14, 2018 12:11 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS